Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
130,702,820
-
Total 13F shares
-
38,416,465
-
Share change
-
-5,054,350
-
Total reported value
-
$878,873,396
-
Put/Call ratio
-
65%
-
Price per share
-
$22.87
-
Number of holders
-
175
-
Value change
-
-$112,542,287
-
Number of buys
-
96
-
Number of sells
-
76
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2021
As of 31 Dec 2021,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,416,465 shares.
The largest 10 holders included
FMR LLC, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NEA Management Company, LLC, BlackRock Inc., PICTET ASSET MANAGEMENT SA, Artal Group S.A., Melqart Asset Management (UK) Ltd, VOLORIDGE INVESTMENT MANAGEMENT, LLC, and CITIGROUP INC.
This page lists
177
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.